Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
775
datasets available to search
ShareScore release 0.9.0
Dataset results
775 results for “irinotecan”
Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
ClinicalTrials.gov study NCT00005076. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of E
ClinicalTrials.gov study NCT07376499. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer
ClinicalTrials.gov study NCT00520091. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
ClinicalTrials.gov study NCT00209638. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)
ClinicalTrials.gov study NCT00990912. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00478634. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT07051785. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer
ClinicalTrials.gov study NCT06486545. IPD Sharing: YES. Countries: 0. Publications: 0.
A Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Te
ClinicalTrials.gov study NCT07092306. IPD Sharing: YES. Countries: 0. Publications: 0.
Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors
ClinicalTrials.gov study NCT06710821. IPD Sharing: NO. Countries: 0. Publications: 0.
Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
ClinicalTrials.gov study NCT05669807. IPD Sharing: NO. Countries: 0. Publications: 0.
Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver
ClinicalTrials.gov study NCT00766220. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan
ClinicalTrials.gov study NCT02747537. IPD Sharing: NO. Countries: 0. Publications: 0.
Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer
ClinicalTrials.gov study NCT06700603. IPD Sharing: NO. Countries: 0. Publications: 0.
A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT06577376. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma
ClinicalTrials.gov study NCT02118064. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma
ClinicalTrials.gov study NCT07356973. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT07134205. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Multi-center, Single-arm, Prospective Non-interventional Study to Investigate the Safety Profiles and Effectiveness of Liposomal Irinotecan (ONIVYDE®) in Combination with 5-fluorouracil (5-FU) and L
ClinicalTrials.gov study NCT06688240. IPD Sharing: NO. Countries: 0. Publications: 0.
Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab
ClinicalTrials.gov study NCT06172036. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.